Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification | Synapse
May 1, 2023Open Access
Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification
Key Points
Key points are not available for this paper at this time.